A Novel Volume Stable Matrix for Gingival Recession Coverage at Teeth

Recruiting N/A Interventional Study
Gingival Recession Connective Tissue Defect
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
University of Bern · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Periodontal health and preservation of the dentition without tooth loss are important quality of life components and should be safeguarded in order to provide optimal function and esthetics. Optimal treatment of gingiva recessions is likely to allow for more efficient use of healthcare resources and reduced costs long-term. It is evident that the prevalence in gingival recession is high and its co…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Written informed consent * Healthy patients referred to the clinic for recession coverage * Miller Class I, II or III facial gingival recession (GR) defect, \>3 mm, located on the buccal of the maxillary or mandibular canine and incisor area. Exclusion Criteria: * History of…
Contacts

Anton Sculean, Prof

+41 31 684 06 20

anton.sculean@unibe.ch

CONTACT

Nikolaos Pandis

+41 31 684 06 40

nikolaos.pandis@unibe.ch

CONTACT